EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

EUR J CLIN PHARMACOL
影响因子:2.7
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:GERMANY
出版社:Springer Berlin Heidelberg
发刊时间:1968
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:0031-6970

期刊介绍

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves-a compound that is interesting and new in some basic or fundamental way, or-methods that are original in some basic sense, or-a highly unexpected outcome, or-conclusions that are scientifically novel in some basic or fundamental sense.
《欧洲临床药理学杂志》发表了关于人类临床药理学和药物治疗各个方面的原创论文。欢迎您就以下主题提交稿件:治疗试验、药代动力学/药效学、药物遗传学、药物代谢、药物不良反应、药物相互作用、药物开发的各个方面、与临床药理学教学相关的开发、药物流行病学以及与合理处方和安全使用药物相关的事项。与这些主题相关的方法学贡献也受到欢迎。来自动物实验的数据仅在同一篇论文中报告的人类原始数据的背景下接受。EJCP只会考虑描述不同人群中等位基因变异频率的手稿,如果这些信息与功能数据或新的有趣变异有关。对相应人群的药物治疗有重大影响的频率差异可能以信函形式提交给编辑。作为新药开发一部分的简明I期药代动力学或药效学研究,只有在论文涉及的化合物在某些基本或基础方面是有趣的和新的,或方法在某些基本意义上是原创的,或者-非常出乎意料的结果,或者-在一些基本或根本意义上的科学新颖的结论。
年发文量 163
国人发稿量 47.94
国人发文占比 0.29%
自引率 -
平均录取率0
平均审稿周期 一般,3-8周
版面费 US$4190
偏重研究方向 医学-药学
期刊官网 https://www.springer.com/228
投稿链接 https://www.editorialmanager.com/ejcl

期刊高被引文献

Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02704-2
Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events?
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02624-1
Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02713-1
Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02711-3
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02815-w
Second-generation antipsychotics and pregnancy complications
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02769-z
Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02656-7
Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02648-7
Balancing medication use in nursing home residents with life-limiting disease
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02649-6
2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02722-0
Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02625-0
Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02804-z
Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02800-3
Spanish list of potentially inappropriate drugs in the elderly (ES-PIA project)
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02684-3
Population pharmacokinetics of meropenem in critically ill children with different renal functions
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02761-7
Use of a personalized phenytoin dosing approach to manage difficult to control seizures in an infant with a SCN2A mutation
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02629-w
Why Z-drugs are used even if doctors and nurses feel unable to judge their benefits and risks—a hospital survey
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02783-1
Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02702-4
Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02731-z
Fatal sulfasalazine-induced DRESS complicated by HHV-6 reactivation and hemophagocytic lymphohistiocytosis
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02809-8
Safety aspects of antiepileptic drugs—a population-based study of adverse effects relative to changes in utilisation
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02678-1
Suspected adverse reactions associated with herbal products used for weight loss: spontaneous reports from the Italian Phytovigilance System
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02746-6
Dried blood spot testing for estimation of renal function and analysis of metformin and sitagliptin concentrations in diabetic patients: a cross-sectional study
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02637-w
Concomitant use of drugs known to cause interactions with oral antiplatelets—polypharmacy in acute coronary syndrome outpatients in Finland
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02777-z
Impact of drugs on venous thromboembolism risk in surgical patients
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02636-x
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02662-9
The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study.
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02801-2
Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥\u200965 years with chronic kidney disease: a randomized clinical trial
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02727-9
Towards a “prescribing license” for medical students: development and quality evaluation of an assessment for safe prescribing
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02686-1
Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02808-9
“It’s helpful to get the time and opportunity to discuss drug treatment; that’s what I think is the most important thing.”—A qualitative study on prescribing education in junior physicians
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02764-4
Medication reconciliation: time to save? A cross-sectional study from one acute hospital
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02750-w
Insulin resistance induced by olanzapine and other second-generation antipsychotics in Chinese patients with schizophrenia: a comparative review and meta-analysis
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02739-5
Evidence synthesis based on non-randomised studies—a critical review of studies leading to conclusions on fall risk properties of loop diuretics/beta-blockers
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02754-6
Correction to: Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02793-z
Letter to the Editor: Clinically relevant drug–drug interactions among elderly people with dementia
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02680-7
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02725-x
Efficacy of triptans for the treatment of acute migraines: a quantitative comparison based on the dose-effect and time-course characteristics
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02748-4
Response to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it’s not
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02728-8
Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02738-6
Effects of guggulsterones-containing thermogenic complex on elvitegravir plasma concentrations: a case report
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02677-2
Pharmacokinetic modeling of intravenous sildenafil in newborns with congenital diaphragmatic hernia
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02767-1
Indications related to antidepressant drug prescribing in the elderly population during 2010-2015 in two primary care databases: the Netherlands and Catalonia (Spain)
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/S00228-019-02685-2
Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02644-x
Letter to editor: Clinically relevant drug–drug interactions among elderly people with dementia
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02679-0
Is vancomycin clearance really correlated with hemoglobin? Arguments that it’s not
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02724-y
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02697-y
Evaluation of the effects of ontogenetic or maturation functions and chronic heart failure on the model analysis for the dose-response relationship of warfarin in Japanese children
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02652-x
Methods for constructing treatment episodes and impact on exposure-outcome associations
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02780-4
Vitamin D blood levels, unnecessary prescriptions, and retest in naïve patients
来源期刊:European Journal of Clinical PharmacologyDOI:10.1007/s00228-019-02759-1

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
67.48%31.17%-1.35%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
3区
2023年12月升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
2022年12月旧的升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
3区